4/A//SEC Filing
Graham G. Walmsley 4/A
Accession 0000935836-24-000764
CIK 0001750284other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 6:52 PM ET
Size
9.5 KB
Accession
0000935836-24-000764
Insider Transaction Report
Form 4/AAmended
Graham G. Walmsley
Director
Transactions
- Sale
Common Stock
2024-12-13$6.75/sh−700,761$4,730,137→ 0 total(indirect: See note) - Purchase
Common Stock
2024-12-13$6.75/sh+700,761$4,730,137→ 700,761 total(indirect: See note)
Holdings
- 708,114(indirect: See note)
Common Stock
Footnotes (6)
- [F1]The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F2]The shares are held by Logos Opportunities Fund IV LP ("Logos Fund IV"). Logos Opportunities IV GP LLC ("GP IV") is the general partner of Logos Fund IV and the reporting person is a managing member of GP IV. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F3]These securities were sold by Logos Fund I to Logos Fund IV. Logos Fund I and Logos Fund IV are under the common control of the Reporting Person.
- [F4]The Form 4 filed on December 17, 2024 identified the transaction date as December 17, 2024. The transaction date was December 13, 2024.
- [F5]The Form 4 filed on December 17, 2024, inadvertently reported the number of shares held by Logos Fund IV after the transaction as 1,408,875. As reported in this amended Form 4, the number of shares held by Logos Fund IV after the transaction is 700,761. The Form 4 also mistakenly reported the purchase of shares by Logos Fund IV as a disposition. The transaction was an acquisition. The transaction date was December 13, 2024.
- [F6]The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The Form 4 filed on December 17, 2024, incorrectly reported these shares as being held by Logos Fund IV.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777517
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 6:52 PM ET
- Size
- 9.5 KB